Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Egalet-002 in moderate-to-severe chronic low back pain
NCT02716857Phase 3Completed
- Sponsor
- Egalet
- Start
- Mar 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone in chronic low back pain (CLBP), sponsored by Egalet. Started Mar 2016; status: completed.
02
Drugs
oxycodone
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02716857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02716857.